Posts

Showing posts with the label Immunohistochemistry Market

Immunohistochemistry Market Is Likely To Witness Huge Growth

  Immunohistochemistry Industry The global immunohistochemistry market size was valued at USD 2.33 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030. Increasing implementation of automation and machine learning in immunohistochemistry (IHC), coupled with the introduction of technologically advanced immunohistochemistry solutions, is expected to significantly drive the market throughout the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced immunohistochemistry systems for disease diagnosis are further propelling the market growth. For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Companies continue to launch novel products to strengthen their market position, which leads to re...

Immunohistochemistry Market To Witness Massive Growth By 2030

  Immunohistochemistry Industry The global  immunohistochemistry market   size is expected to reach USD 3.50 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 5.8% from 2023 to 2030. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology. The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug disco...

Immunohistochemistry Market To Grow Substantially At A CAGR Of 5.8% From 2023 To 2030

  Immunohistochemistry Industry Overview The global immunohistochemistry market size was valued at USD 2.33 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030. Increasing implementation of automation and machine learning in immunohistochemistry (IHC), coupled with the introduction of technologically advanced immunohistochemistry solutions, is expected to significantly drive the market throughout the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced immunohistochemistry systems for disease diagnosis are further propelling the market growth. Gather more insights about the market drivers, restrains and growth of the  Immunohistochemistry Market For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-...

Immunohistochemistry Market Size Worth $3.92 Billion By 2030

Immunohistochemistry Industry Overview The global immunohistochemistry market size was valued at USD 1.89 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030.  Increasing implementation of automation and machine learning in IHC, coupled with the introduction of technologically advanced Immunohistochemistry (IHC) solutions, is expected to significantly drive the market over the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further propelling the market growth. Gather more insights about the market drivers, restrains and growth of the Global Immunohistochemistry Market For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Companies...